Details for New Drug Application (NDA): 088911
✉ Email this page to a colleague
The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 088911
Tradename: | BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
Applicant: | Fresenius Kabi Usa |
Ingredient: | sodium chloride |
Patents: | 0 |
Pharmacology for NDA: 088911
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 088911
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | SOLUTION;INJECTION | 088911 | ANDA | Fresenius Kabi USA, LLC | 63323-924 | 63323-924-10 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-10) / 10 mL in 1 VIAL, MULTI-DOSE (63323-924-01) |
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | SOLUTION;INJECTION | 088911 | ANDA | Fresenius Kabi USA, LLC | 63323-924 | 63323-924-30 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-924-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 270MG/30ML (9MG/ML) | ||||
Approval Date: | Feb 7, 1985 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 90MG/10ML (9MG/ML) | ||||
Approval Date: | May 17, 1985 | TE: | AP | RLD: | No |
Complete Access Available with Subscription